av/brooklyn-immunotherapeutics--big.svg

NASDAQ:BTX

Eterna Therapeutics Inc.

  • Stock

USD

Last Close

0.20

17/10 04:00

Market Cap

1.05M

Beta: 0.79

Volume Today

2.56M

Avg: 85.42K

PE Ratio

−0.42

PFCF: −0.39

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '20
Jun '20
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
net income
-1.02M
-
-2.03M
99.51%
-2.02M
0.65%
-2.22M
9.80%
-17.70M
698.05%
-10.09M
43.03%
-86.06M
753.27%
-8.46M
90.17%
-9.38M
10.78%
-3.40M
63.75%
-7.32M
115.33%
-4.49M
38.65%
-5.42M
20.65%
-4.51M
16.77%
-5.59M
24.02%
-6.15M
10.05%
-6.65M
8.03%
depreciation and amortization
23.00K
-
24.64K
7.13%
25.27K
2.57%
25.09K
0.71%
94.90K
278.23%
117.28K
23.59%
123.42K
5.23%
123.40K
0.02%
138K
11.83%
152K
10.14%
121K
20.39%
86K
28.93%
62K
27.91%
63K
1.61%
517K
720.63%
481K
6.96%
541K
12.47%
deferred income tax
9.60M
-
50K
99.48%
-297.28K
694.56%
106
100.04%
-190K
-
-20K
89.47%
210K
1,150%
stock based compensation
22.73K
-
22.73K
0%
22.73K
0%
22.80K
0.28%
169.00K
641.28%
1.40M
731.02%
1.73M
23.06%
1.93M
11.86%
1.18M
38.81%
879K
25.70%
476K
45.85%
397K
16.60%
689K
73.55%
214K
68.94%
174K
18.69%
165K
5.17%
282K
70.91%
change in working capital
-899.61K
-
-197.46K
78.05%
-434.52K
120.06%
532.59K
222.57%
-784.98K
247.39%
1.96M
349.52%
-2.53M
229.14%
-994.18K
60.70%
399K
140.13%
2.21M
452.63%
1.45M
34.29%
-343K
123.67%
-1.48M
331.49%
-34K
97.70%
-958K
2,717.65%
355K
137.06%
accounts receivables
4.68K
-
-663.68K
-
-232K
-
-25K
89.22%
304K
1,316%
-337K
210.86%
-792K
135.01%
1.35M
270.71%
inventory
232K
-
25K
89.22%
-304K
1,316%
337K
210.86%
792K
135.01%
-825K
204.17%
accounts payables
486K
-
1.81M
272.22%
-919K
150.80%
2.03M
321.33%
-1.77M
186.82%
1.31M
174.29%
1.67M
26.98%
-4.11M
346.70%
461K
111.22%
other working capital
-789.66K
-
-330.50K
-
-87K
73.68%
396K
555.17%
2.37M
497.98%
-2.38M
200.38%
286K
112.03%
-1.35M
570.63%
-2.62M
94.95%
3.94M
250.08%
other non cash items
5.20M
-
-249.91K
104.81%
80.61M
32,355.28%
570.04K
99.29%
2.22M
289.97%
-3.83M
272.33%
-845K
77.94%
-1.09M
28.52%
96K
108.84%
583K
507.29%
52K
91.08%
281K
440.38%
net cash provided by operating activities
-1.87M
-
-2.18M
16.57%
-2.41M
10.22%
-1.64M
31.95%
-3.43M
109.43%
-6.80M
98.40%
-6.42M
5.61%
-6.83M
6.34%
-5.43M
20.47%
-3.99M
26.49%
-6.12M
53.17%
-5.43M
11.13%
-6.05M
11.30%
-3.87M
35.99%
-5.83M
50.46%
-4.66M
20.00%
-3.75M
19.61%
investments in property plant and equipment
-4.46K
-
-21.72K
387.32%
-12.82K
-
-6.86K
-
-147.14K
2,044.90%
-46K
68.74%
-187K
306.52%
-43K
77.01%
-21K
51.16%
-19K
-
-101K
431.58%
acquisitions net
147.73K
-
-466
100.32%
-22.85M
4,904,107.73%
-654
100.00%
150K
-
purchases of investments
sales maturities of investments
other investing activites
118.59K
-
406
-
100K
-
4K
-
net cash used for investing activites
-4.46K
-
-21.72K
387.32%
-12.82K
-
266.32K
2,176.91%
-466
100.17%
-22.86M
4,905,579.83%
-147.39K
99.36%
-46K
68.79%
-87K
89.13%
-43K
50.57%
129K
400%
-19K
-
-97K
410.53%
debt repayment
-531.99K
-
-410.01K
-
-1K
-
-1K
0%
-8.54M
-
-7.71M
9.70%
common stock issued
312.50K
-
3.55M
1,034.80%
500.25K
-
10.48M
1,993.97%
48.55M
363.48%
3.50M
92.79%
-414
100.01%
11.99M
2,896,959.90%
7K
-
7.71M
110,085.71%
320K
-
common stock repurchased
dividends paid
-8K
-
-8K
-
-8K
-
other financing activites
309.90K
-
275K
11.26%
-274.90K
199.97%
10.20K
-
-8.20K
-
-13K
-
-111K
-
17.08M
-
15.42M
9.70%
1.39M
91.02%
net cash used provided by financing activities
312.50K
-
3.86M
1,133.97%
275K
92.87%
225.34K
18.06%
9.94M
4,312.38%
48.56M
388.38%
3.50M
92.79%
-418.62K
111.96%
11.99M
2,964.88%
-13K
100.11%
6K
146.15%
7.59M
126,450%
312K
-
8.54M
2,637.18%
7.70M
9.79%
1.39M
82.02%
effect of forex changes on cash
181
-
-455
-
net change in cash
-1.57M
-
1.65M
205.49%
-2.13M
229.12%
-1.43M
33.15%
6.78M
575.75%
41.75M
515.90%
-25.78M
161.75%
-7.40M
71.31%
6.51M
188.08%
-4.09M
162.82%
-6.15M
50.33%
2.29M
137.17%
-6.05M
364.49%
-3.56M
41.15%
2.71M
176.24%
3.02M
11.42%
-2.46M
181.32%
cash at beginning of period
5.10M
-
3.54M
30.68%
5.19M
46.69%
3.06M
41.10%
1.63M
46.63%
8.41M
415.80%
50.16M
496.49%
24.38M
51.40%
16.98M
30.34%
23.50M
38.36%
19.41M
17.42%
13.25M
31.71%
15.54M
17.26%
9.49M
38.92%
5.93M
37.51%
4.55M
23.28%
11.67M
156.43%
cash at end of period
3.54M
-
5.19M
46.69%
3.06M
41.10%
1.63M
46.65%
8.41M
415.95%
50.16M
496.49%
24.38M
51.40%
16.98M
30.34%
23.50M
38.36%
19.41M
17.42%
13.25M
31.71%
15.54M
17.26%
9.49M
38.92%
5.93M
37.51%
8.65M
45.75%
7.58M
12.39%
9.21M
21.60%
operating cash flow
-1.87M
-
-2.18M
16.57%
-2.41M
10.22%
-1.64M
31.95%
-3.43M
109.43%
-6.80M
98.40%
-6.42M
5.61%
-6.83M
6.34%
-5.43M
20.47%
-3.99M
26.49%
-6.12M
53.17%
-5.43M
11.13%
-6.05M
11.30%
-3.87M
35.99%
-5.83M
50.46%
-4.66M
20.00%
-3.75M
19.61%
capital expenditure
-4.46K
-
-21.72K
387.32%
-12.82K
-
-6.86K
-
-147.14K
2,044.90%
-46K
68.74%
-187K
306.52%
-43K
77.01%
-21K
51.16%
-19K
-
-101K
431.58%
free cash flow
-1.88M
-
-2.21M
17.45%
-2.41M
9.13%
-1.65M
31.42%
-3.43M
107.81%
-6.80M
98.40%
-6.43M
5.51%
-6.98M
8.52%
-5.48M
21.49%
-4.18M
23.69%
-6.16M
47.34%
-5.46M
11.41%
-6.05M
10.87%
-3.87M
35.99%
-5.83M
50.46%
-4.68M
19.67%
-3.85M
17.78%

All numbers in USD (except ratios and percentages)